CLINICAL_TRIALS
trial_result
· 2026-04-06
Clinical Trial Update: A Study to Evaluate CM336 in Adults With Autoimmune Bullous Disease [Phase 2]
Summary
A Phase 2 clinical trial evaluating CM336 in adults with autoimmune bullous disease is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shandong First Medical University | Conditions: Autoimmune Bullous Disease | Phase 2 | Status: RECRUITING